Monoclonal antibodies targeting the disintegrin-like domain of ADAMDEC1 modulates the proteolytic activity and enables quantification of ADAMDEC1 protein in human plasma

Míreanna comhchosúla

• Evidence for Restricted Reactivity of ADAMDEC1 with Protein Substrates and Endogenous Inhibitors.
  de réir: Lund, J, et al.
  Foilsithe / Cruthaithe: (2015)
• ADAMDEC1 accelerates GBM progression via activation of the MMP2-related pathway
  de réir: Huimin Qi, et al.
  Foilsithe / Cruthaithe: (2022-09-01)
• ADAMDEC1 promotes the malignant progression of cholangiocarcinoma by regulating NF-κB signaling pathway
  de réir: Shuo Zhou, et al.
  Foilsithe / Cruthaithe: (2025-01-01)
• ADAMDEC1 and FGF2/FGFR1 signaling constitute a positive feedback loop to maintain GBM cancer stem cells
  de réir: Ana Jimenez-Pascual, et al.
  Foilsithe / Cruthaithe: (2020-01-01)
• Low density lipoprotein receptor-related protein 1 (LRP1)-mediated endocytic clearance of a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4): functional differences of non-catalytic domains of ADAMTS-4 and ADAMTS-5 in LRP1 binding.
  de réir: Yamamoto, K, et al.
  Foilsithe / Cruthaithe: (2014)